StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.55+0.18 (+4.12%)

Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –

Alvotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Alvotech's price to sales ratio was 3.0× on Nov 11, 2026, against 3.2× a year earlier. Over the last 5 years it ranged from 0.1× to 95.0×, with a median of 5.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.0×−0.3
2025Dec 31, 20253.3×−37.2
2024Dec 31, 202440.4×+3.6
2023Dec 29, 202336.8×+36.5
2022Dec 30, 20220.2×−13.6
2021Dec 31, 202113.9×–

More Alvotech figures

See a number that looks wrong?